منابع مشابه
Ofatumumab Monoclonal Antibody Affinity Maturation Through in silico Modeling
Background: Ofatumumab, an anti-CD20 mAb, was approved in 2009 for the treatment of chronic lymphocytic leukemia. This mAb acts through immune-mediated mechanisms, in particular complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity by natural killer cells as well as antibody-dependent phagocytosis by macrophages. Apoptosis induction is another mechanism of this antibody...
متن کامل1086 Monoclonal Antibody Against
Immune response (Ir) loci that map in the I region of the H-2 gene complex regulate the capacity to generate an immune response against numerous foreign antigens (1). Loci that map in the I region also control polymorphic~cell surface antigens that are expressed in immunocompetent cells (I-region-associated antigens or Ia loci) (2) and antigens that stimulate T cell proliferative responses betw...
متن کاملproduction of monoclonal antibody against alkylhydroperoxide reductase
development of a stool antigen immunoassay to detect helicobacter pylori infection requires monoclonal antibody against the specific antigen. alkylhydroperoxide reductase (ahpc) of helicobacter pylori has been described as a specific and unique enzyme for h. pylori and therefore, both h. pylori ahpc and anti-ahpc could be useful in the development of serologic and stool antigen tests, for detec...
متن کاملproduction of monoclonal antibody against human immunoglobulin
immunoglobulin e is one of the five classes of immonoglobulins that plays an important role in allergic diseases. production of monoclonal antibodies by a single clonotype against different epitopes of immunoglobulin e has high priority in development of diagnostic kits. in this study, an attempt was made to produce monoclonal antibodies against human immunoglobulin e. balb/c mice were immunize...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: mAbs
سال: 2009
ISSN: 1942-0862,1942-0870
DOI: 10.4161/mabs.1.2.7638